Financial reports
10-K
2023 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
17 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
21 Mar 24
8-K
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
19 Mar 24
8-K
Departure of Directors or Certain Officers
22 Feb 24
8-K
Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review process
20 Feb 24
8-K
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
12 Feb 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Departure of Directors or Certain Officers
17 Nov 23
8-K
Departure of Directors or Certain Officers
15 Nov 23
8-K
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9 Nov 23
8-K
Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration
7 Nov 23
Registration and prospectus
8-A12B
Registration of securities on exchange
20 Feb 24
424B4
Prospectus supplement with pricing info
2 Oct 23
S-1MEF
Registration of additional securities for an S-1
28 Sep 23
S-1/A
IPO registration (amended)
28 Sep 23
S-1/A
IPO registration (amended)
26 Sep 23
S-1
IPO registration
8 Sep 23
424B5
Prospectus supplement for primary offering
4 Apr 23
S-8
Registration of securities for employees
29 Mar 23
S-8
Registration of securities for employees
29 Mar 23
S-8
Registration of securities for employees
17 Mar 22
Proxies
DEF 14A
Definitive proxy
1 Sep 23
PRE 14A
Preliminary proxy
21 Aug 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
PRE 14A
Preliminary proxy
21 Apr 23
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
DEFA14A
Additional proxy soliciting materials
17 Apr 20
Other
EFFECT
Notice of effectiveness
29 Sep 23
CORRESP
Correspondence with SEC
26 Sep 23
CORRESP
Correspondence with SEC
26 Sep 23
UPLOAD
Letter from SEC
25 Sep 23
CORRESP
Correspondence with SEC
20 Sep 23
UPLOAD
Letter from SEC
15 Sep 23
UPLOAD
Letter from SEC
11 Sep 23
EFFECT
Notice of effectiveness
2 Aug 21
CORRESP
Correspondence with SEC
29 Jul 21
UPLOAD
Letter from SEC
28 Jul 21
Ownership
3
Mary Beth Dooley
21 Mar 24
4
James P Flynn
21 Mar 24
3
James P Flynn
21 Mar 24
144
Notice of proposed sale of securities
21 Mar 24
3
Jacob Ma-Weaver
16 Feb 24
SC 13D
Funicular Funds, LP
16 Feb 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
Kryzanowski John A
14 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Patricia N. Hurter
4 Jan 24